Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. (ADVM) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ADVM · as of Jun 9, 2026
Activity summary
Buy transactions
20
P-Purchase only
Sell transactions
7
12 Months
Buy/Sell ratio
2.86
Buy/Sell (by trades)
Overall sentiment
Adverum Biotechnologies, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ADVM insider buying and selling by quarter
ADVM insider selling · ADVM insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ADVM ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ADVM executive sell shares · ADVM board member insider trading · ADVM insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Dec 9, 2025 | Fischer Laurent CEO, PRESIDENT AND DIRECTOR · Director | Option | 150,000 | $630K | Form 4 |
| Dec 9, 2025 | Fischer Laurent CEO, PRESIDENT AND DIRECTOR · Director | Other | 351,513 | $1.25M⚡ | Form 4 |
| Dec 9, 2025 | Soparkar Peter CHIEF OPERATING OFFICER | Other | 80,189 | $285K | Form 4 |
| Dec 9, 2025 | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | Other | 54,874 | $195K | Form 4 |
| Dec 9, 2025 | Rubinstein Linda M CHIEF FINANCIAL OFFICER | Option | 48,750 | $205K | Form 4 |
| Dec 9, 2025 | Rubinstein Linda M CHIEF FINANCIAL OFFICER | Other | 61,150 | $218K | Form 4 |
| Dec 9, 2025 | Svoronos Dawn Director | Other | 5,000 | $18K | Form 4 |
| Dec 9, 2025 | Scopa James Paul Director | Other | 10,333 | $37K | Form 4 |
| Dec 9, 2025 | Lupher, Jr. Mark L. Director | Other | 13,000 | $46K | Form 4 |
| Dec 9, 2025 | Machado Patrick Director | Other | 8,818 | $31K | Form 4 |
Fischer Laurent
CEO, PRESIDENT AND DIRECTOR · Director
Date
Dec 9
Shares
150,000
Price
$4.20
Value
$630K
Fischer Laurent
CEO, PRESIDENT AND DIRECTOR · Director
Date
Dec 9
Shares
351,513
Price
$3.56
Value
$1.25M ⚡
Soparkar Peter
CHIEF OPERATING OFFICER
Date
Dec 9
Shares
80,189
Price
$3.56
Value
$285K
Seyedkazemi Setareh
CHIEF DEVELOPMENT OFFICER
Date
Dec 9
Shares
54,874
Price
$3.56
Value
$195K
Rubinstein Linda M
CHIEF FINANCIAL OFFICER
Date
Dec 9
Shares
48,750
Price
$4.20
Value
$205K
Rubinstein Linda M
CHIEF FINANCIAL OFFICER
Date
Dec 9
Shares
61,150
Price
$3.56
Value
$218K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ADVM insider trading
ADVM insider trades
Adverum Biotechnologies, Inc. (ADVM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Fischer Laurent (CEO, PRESIDENT AND DIRECTOR · Director), Rubinstein Linda M (CHIEF FINANCIAL OFFICER), Soparkar Peter (CHIEF OPERATING OFFICER). Over the past 12 months, 5 insiders have filed transactions with the SEC. ADVM insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Adverum Biotechnologies, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ADVM insider trading · 5 questionsThe insiders of Adverum Biotechnologies, Inc. (ADVM) include executives and directors such as Fischer Laurent (CEO, PRESIDENT AND DIRECTOR · Director), Rubinstein Linda M (CHIEF FINANCIAL OFFICER), Soparkar Peter (CHIEF OPERATING OFFICER), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026